No abstract available.
Benzodiazepines*

Clobazam is one of the benzodiazepine compounds consisting of different structure compared to previously marketed other benzodiazepines. In rescent days, the antiepileptic effects of this drug has been recognized and used in epileptic patients. To confirm the efficacy and side effects of clobazam, we review the records of the 60 patients who was medicated clobazam more than 9 months. These patients had complex partial seizure with unsatisfactory control despite of adequate drug dosage and duration. Among these patients, the improved one were 23 (38. 3%), and tolerant one were 25 with 5.6 month mean remission duration. Only the 7 of 60 patients complained the adverse symptoms and this were not serious enough to discontinue medication. In conclusion, clobazam is relatively safe and efficacious medication enough to try for patients with unsatisfactory seizure control.
Benzodiazepines ; Humans ; Seizures

Basing on common chemical reactions, thin layer chromato graphy, absouptive ultraviolet spectrum some parameters were determined for preparation containing benzodiazepine in HCM City. The efficiency of extraction of benzodiazepan in 6 self made sample: Rhino sweet drink, coca-cola, combined food, soya milk, 333 beer and urine. Results found 17 active substances of diazepine group in 131 specialities of commercial propriatary name in HCM City, where diazepam had accounted higher rate in narcotic intoxixation cases. In criminal cases involved in tranquillisant narcotics, the most common substance were diazepan, flunitrazepan, clonazepan, bromazepan, alprazolam, clorazepat, oxazepan and nor-diazepan
Benzodiazepines ; Pharmaceutical Preparations ; Chemistry

Humans ; Benzodiazepines ; Hypnotics and Sedatives ; Prescriptions

In 54 cases with heterophoria, the effects of the tranquilizers were studied. The minimum doses of two kinds of tranquilizers i.e., phenothiazine derivative (chlorpromazine) and benzodiazepine derivative (oxazepam) were given for 3 days. The results were as follows: 1. In 18 cases (43%) of the 30 cases who complained asthenopia, the symptom was relieved to some extent. The improvement of the symptom occurred with decrease in the Jateral phoria in 13 cases, and with increase in fusional amplitude in 13 cases. 2, There were no changes in the lateral phoria in 31 cases (59%) at distance, but at near, in 27 cases (52%) there was decrease in the lateral phoria. The amount of the increment or decrement in prism diopters was somewhat larger at near than at distance, and also somewhat larger in cases, in which the initial lateral phoria before medication is high, than in the cases with low initial lateral phoria. 3, There were no changes in the fusional amplitude in 24 cases (46%) at distance, but at near, in 28 cases (55 %) there was the increase in fusional amplitude. The changes in the amount of the increment or decrement in the fusional al1}plitude were similar to that of the changes in the amount in lateral phoria. 4, There were no remarkable changes in vertical phorias. 5. In exophoria there were no remarkable differences between subjects given chlorpromazine and those gIven oxazepam.
Asthenopia ; Benzodiazepines ; Chlorpromazine ; Exotropia ; Oxazepam ; Strabismus

No abstract available.
Benzodiazepines* ; gamma-Aminobutyric Acid* ; Receptors, GABA-A*

Posthypoxic myoclonus is poorly controlled with current treatments. Based on clinical experience, valproate and benzodiazepines have been used to treat myoclonic seizures. Rarely, some antiepileptic drugs may exacerbate myoclonic seizures. Although lamotrigine is controversial for treatment in myoclonic seizures, we experience a case of posthypoxic myoclonus improved with lamotrigine add-on therapy.
Anticonvulsants ; Benzodiazepines ; Myoclonus* ; Seizures ; Valproic Acid

Tardive dystonia is an uncommon late side-effect of neuroleptic drug treatment and a difficult condition to treat. We report a single case of tardive dystonia that has successfully responded to clozapine. This patient has undergone more than thirteen years of antipsychotic treatment and developed severe and persistent tardive dystonia. Treatment with benzodiazepine, anticholinergics and muscle relaxant were ineffective in this patient. Thus, clozapine was tried. Treatment with clozapine brought about marked improvement and this remission has been sustained. We reviewed the literatures about successful treatment of tardive dystonia with clozapine. Finally, we recommend a trial of clozapine in adequate doses and for adequate duration on patients with drug-induced tardive dystonia.
Benzodiazepines ; Cholinergic Antagonists ; Clozapine* ; Humans ; Movement Disorders* ; Schizophrenia*

PURPOSE: To describe the surgical treatment of the complex dorsal metacarpophalangeal dislocations and its results, emphasizing on the modified volar approach with A1 pulley release. MATERIALS AND METHODS: We experienced 6 cases of dorsal dislocation of the metacarpophalangeal joint. We performed open reduction with the modified volar approach described by Eaton and Dray. Postoperatively posteroanterior and lateral radiographs of the index finger metacarpophalangeal joint and metacarpophalangeal joint range of motion was followed. RESULTS: One case with a large osteochondral fracture was operated with volar and doral approach both. Overall end results were good without any significant restriction of motion and stability of the fingers. CONCLUSION: Modified volar approach with A1 pulley release is an excellent method for complex dorsal metacarpophalangeal dislocations without osteochondral fracture.
Benzodiazepines ; Dislocations ; Fingers ; Metacarpophalangeal Joint ; Range of Motion, Articular

The effects of lorazepam on cerebral function, metabolism, and hemodynamics were studied in eight dogs receiving a general anesthesia with isoflurane(0.5 vo1%)-50% nitrous oxide-oxy-gen. The effects of benzodiazepine antaronist, flumazenil, were also examined. Lorazepam(0.5 mg/kg) administration did decrease mean arterial pressure(MAP) and herat rate(HR). It did significantly decrease cerebral blood flow(CBF)(measured by posterior sagittal sinus outflow method) by 25% of control value(68+/-l3 vs. 51+/-12ml/100gm/min, meanSD) and cereberal metabolic rate for oxygen(CMRO ) by 17% (3.96+/-1.04 vs. 3.30+/-0.92ml/l00gm/min, mean+/-SD). Electroencephalogram(EEG) converted to high amplitude, predominantly theta and delta activity. Intracranial pressure(ICP) increased markedly. Following flumazenil(0.06 mg/kg) administration, HR recovered completely to control level but MAP increased only at 5 min. compared to pre-flumazenil value and returned to pre-flumazenil level. CBF recovered to control level for 15 min. and deereased after 30 min. compared to control level but higher than pre-flumazenil level about 9-15%. CMRO recovered completely to control leveL EEG changed to an awake pattern after fluamzenil administration. It is concluded that lorarepam decreased cerebral function and metabolism and depressed hemodynamic fuction. Benzodiazepine antag- onist, flumazenil, was effective in reversing cerebral and hemodynamic effects, may be in dose related manner.
Anesthesia, General ; Animals ; Benzodiazepines ; Dogs* ; Electroencephalography ; Flumazenil* ; Hemodynamics ; Lorazepam* ; Metabolism